These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 25887468)

  • 21. Substrate accumulation and extracellular matrix remodelling promote persistent upper airway disease in mucopolysaccharidosis patients on enzyme replacement therapy.
    Pal AR; Mercer J; Jones SA; Bruce IA; Bigger BW
    PLoS One; 2018; 13(9):e0203216. PubMed ID: 30226843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progression of Hip Dysplasia in Mucopolysaccharidosis Type I Hurler After Successful Hematopoietic Stem Cell Transplantation.
    Langereis EJ; den Os MM; Breen C; Jones SA; Knaven OC; Mercer J; Miller WP; Kelly PM; Kennedy J; Ketterl TG; O'Meara A; Orchard PJ; Lund TC; van Rijn RR; Sakkers RJ; White KK; Wijburg FA
    J Bone Joint Surg Am; 2016 Mar; 98(5):386-95. PubMed ID: 26935461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of haemopoietic stem cell transplantation on the ocular phenotype in mucopolysaccharidosis type I (Hurler).
    Javed A; Aslam T; Jones SA; Mercer J; Tyler K; Church H; Ghosh A; Wynn R; Sornalingam K; Ashworth J
    Acta Ophthalmol; 2018 Aug; 96(5):494-498. PubMed ID: 29240299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement.
    Hampe CS; Wesley J; Lund TC; Orchard PJ; Polgreen LE; Eisengart JB; McLoon LK; Cureoglu S; Schachern P; McIvor RS
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33572941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Children with a history of prematurity presenting with snoring and sleep-disordered breathing: a cross-sectional study.
    Manuel A; Witmans M; El-Hakim H
    Laryngoscope; 2013 Aug; 123(8):2030-4. PubMed ID: 23606206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term efficacy of hematopoietic stem cell transplantation on brain involvement in patients with mucopolysaccharidosis type II: a nationwide survey in Japan.
    Tanaka A; Okuyama T; Suzuki Y; Sakai N; Takakura H; Sawada T; Tanaka T; Otomo T; Ohashi T; Ishige-Wada M; Yabe H; Ohura T; Suzuki N; Kato K; Adachi S; Kobayashi R; Mugishima H; Kato S
    Mol Genet Metab; 2012 Nov; 107(3):513-20. PubMed ID: 23022072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improvement in time to treatment, but not time to diagnosis, in patients with mucopolysaccharidosis type I.
    Giugliani R; Muschol N; Keenan HA; Dant M; Muenzer J
    Arch Dis Child; 2021 Jul; 106(7):674-679. PubMed ID: 33139350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrastructural analysis of dermal fibroblasts in mucopolysaccharidosis type I: Effects of enzyme replacement therapy and hematopoietic cell transplantation.
    Cox-Brinkman J; van den Bergh Weerman MA; Wijburg FA; Aerts JM; Florquin S; van der Lee JH; Hollak CE
    Ultrastruct Pathol; 2010 May; 34(3):126-32. PubMed ID: 20455661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical manifestations and treatment of mucopolysaccharidosis type I patients in Latin America as compared with the rest of the world.
    Muñoz-Rojas MV; Bay L; Sanchez L; van Kuijck M; Ospina S; Cabello JF; Martins AM
    J Inherit Metab Dis; 2011 Oct; 34(5):1029-37. PubMed ID: 21541721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-transplant laronidase augmentation for children with Hurler syndrome: biochemical outcomes.
    Lund TC; Miller WP; Liao AY; Tolar J; Shanley R; Pasquali M; Sando N; Bigger BW; Polgreen LE; Orchard PJ
    Sci Rep; 2019 Oct; 9(1):14105. PubMed ID: 31575939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone Remodeling in an Mps-1h Girl after Hematopoietic Stem Cell Transplantation along with Enzymatic Replacement Therapy.
    Tummolo A; Brunetti G; Piacente L; Marzollo A; Biffi A; Burlina A; Faienza MF
    Endocr Metab Immune Disord Drug Targets; 2022; 22(14):1425-1432. PubMed ID: 35619307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enzyme replacement therapy prior to haematopoietic stem cell transplantation in Mucopolysaccharidosis Type I: 10 year combined experience of 2 centres.
    Ghosh A; Miller W; Orchard PJ; Jones SA; Mercer J; Church HJ; Tylee K; Lund T; Bigger BW; Tolar J; Wynn RF
    Mol Genet Metab; 2016 Mar; 117(3):373-7. PubMed ID: 26832957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Residual α-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients.
    Oussoren E; Keulemans J; van Diggelen OP; Oemardien LF; Timmermans RG; van der Ploeg AT; Ruijter GJ
    Mol Genet Metab; 2013 Aug; 109(4):377-81. PubMed ID: 23786846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mucopolysaccharidoses I and II: Brief Review of Therapeutic Options and Supportive/Palliative Therapies.
    Nan H; Park C; Maeng S
    Biomed Res Int; 2020; 2020():2408402. PubMed ID: 33344633
    [No Abstract]   [Full Text] [Related]  

  • 35. Current hypopnea scoring criteria underscore pediatric sleep disordered breathing.
    Lin CH; Guilleminault C
    Sleep Med; 2011 Aug; 12(7):720-9. PubMed ID: 21700494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progression of organ manifestations upon enzyme replacement therapy in a patient with mucopolysaccharidosis type I/Hurler.
    Mercimek-Mahmutoglu S; Reilly C; Human D; Waters PJ; Stoeckler-Ipsiroglu S
    World J Pediatr; 2009 Nov; 5(4):319-21. PubMed ID: 19911152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hurler syndrome: early diagnosis and treatment].
    Leroux S; Muller JB; Boutaric E; Busnel A; Lemouel F; Andro-Garçon M; Neven B; Valayannopoulos V; Vinceslas C
    Arch Pediatr; 2014 May; 21(5):501-6. PubMed ID: 24698225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined enzyme replacement and haematopoietic stem cell transplantation in Hurler syndrome.
    Bijarnia S; Shaw P; Vimpani A; Smith R; Pacey V; O'Grady H; Christodoulou J; Sillence D
    J Paediatr Child Health; 2009; 45(7-8):469-72. PubMed ID: 19712183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activities of daily living in patients with Hunter syndrome: impact of enzyme replacement therapy and hematopoietic stem cell transplantation.
    Tanjuakio J; Suzuki Y; Patel P; Yasuda E; Kubaski F; Tanaka A; Yabe H; Mason RW; Montaño AM; Orii KE; Orii KO; Fukao T; Orii T; Tomatsu S
    Mol Genet Metab; 2015 Feb; 114(2):161-9. PubMed ID: 25468646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obstructive sleep apnea and craniofacial appearance in MPS type I-Hurler children after hematopoietic stem cell transplantation.
    Koehne T; Müller-Stöver S; Köhn A; Stumpfe K; Lezius S; Schmid C; Lukacs Z; Kahl-Nieke B; Muschol N
    Sleep Breath; 2019 Dec; 23(4):1315-1321. PubMed ID: 31332621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.